Literature DB >> 23955613

Is neuroinflammation involved in the development of dementia in patients with Parkinson's disease?

In-Uk Song1, Young-Do Kim, Hyun-Ji Cho, Sung-Woo Chung.   

Abstract

OBJECTIVE: High-sensitivity C-reactive protein (hs-CRP) is an extremely sensitive systemic marker of inflammation and tissue damage, and increased levels of hs-CRP are strongly associated with inflammatory reactions. Microglia-mediated neuroinflammation has been hypothesized to play an important role in the pathogenesis of idiopathic Parkinson's disease (PD). However, the clinical value of the hs-CRP level in patients with PD is poorly defined. Therefore, we conducted this study to analyze the differences in the hs-CRP levels in PD patients with and without dementia.
METHODS: We examined 72 PD patients without dementia (PDwoD) and 45 PD patients with dementia (PDD), as well as 84 control subjects. We investigated the differences in the hs-CRP and fibrinogen levels between these three groups.
RESULTS: The mean hs-CRP and fibrinogen values were not significantly different between the PDwoD and PDD groups; however, these two groups had significantly higher mean hs-CRP and fibrinogen values than the control group.
CONCLUSION: It is known that inflammation plays a role in the pathogenesis of PD and dementia. However, based on the results of this study, we cautiously speculate that although neuroinflammation plays a role in the development of neurodegenerative diseases, including PD and dementia, it may be unrelated to the pathogenesis of dementia in patients with PD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23955613     DOI: 10.2169/internalmedicine.52.0474

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  12 in total

1.  Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.

Authors:  Christopher J Barnum; Xi Chen; Jaegwon Chung; Jianjun Chang; Martha Williams; Nelly Grigoryan; Raymond J Tesi; Malú G Tansey
Journal:  J Parkinsons Dis       Date:  2014       Impact factor: 5.568

2.  High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease.

Authors:  Aslıhan Baran; Mahmut Bulut; Mehmet Cemal Kaya; Özlem Demirpençe; Bünyamin Sevim; Eşref Akıl; Sefer Varol
Journal:  Neurol Sci       Date:  2018-10-23       Impact factor: 3.307

3.  The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease.

Authors:  Eşref Akıl; Aslıhan Bulut; İbrahim Kaplan; Hasan Hüseyin Özdemir; Demet Arslan; Mehmet Ufuk Aluçlu
Journal:  Neurol Sci       Date:  2014-10-07       Impact factor: 3.307

4.  The Association Between Neuropsychological Function with Serum Vitamins A, D, and E and hs-CRP Concentrations.

Authors:  Afsane Bahrami; Hamidreza Bahrami-Taghanaki; Zahra Khorasanchi; Maryam Tayefi; Gordon A Ferns; Hamid Reza Sadeghnia; Majid Ghayour-Mobarhan
Journal:  J Mol Neurosci       Date:  2019-04-09       Impact factor: 3.444

5.  Eryptosis as a marker of Parkinson's disease.

Authors:  Etheresia Pretorius; Albe C Swanepoel; Antoinette V Buys; Natasha Vermeulen; Wiebren Duim; Douglas B Kell
Journal:  Aging (Albany NY)       Date:  2014-10       Impact factor: 5.682

Review 6.  Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's Disease.

Authors:  Giulia Sita; Patrizia Hrelia; Andrea Tarozzi; Fabiana Morroni
Journal:  Int J Mol Sci       Date:  2016-09-01       Impact factor: 5.923

7.  Early microglial activation and peripheral inflammation in dementia with Lewy bodies.

Authors:  Ajenthan Surendranathan; Li Su; Elijah Mak; Luca Passamonti; Young T Hong; Robert Arnold; Patricia Vázquez Rodríguez; William R Bevan-Jones; Susannah A E Brain; Tim D Fryer; Franklin I Aigbirhio; James B Rowe; John T O'Brien
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

8.  C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Xiaohui Qiu; Yousheng Xiao; Jingjing Wu; Lu Gan; Yanning Huang; Jin Wang
Journal:  Front Neurol       Date:  2019-04-17       Impact factor: 4.003

9.  Relationship between the hs-CRP as non-specific biomarker and Alzheimer's disease according to aging process.

Authors:  In-Uk Song; Sung-Woo Chung; Young-Do Kim; Lee-So Maeng
Journal:  Int J Med Sci       Date:  2015-07-16       Impact factor: 3.738

10.  Can the disease course in Parkinson's disease be slowed?

Authors:  Amos D Korczyn; Sharon Hassin-Baer
Journal:  BMC Med       Date:  2015-12-10       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.